Category: 3. Business

Specialty

Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI’m not a medical professional.Infectious DiseaseIntegrative/Complementary MedicineInternal MedicineInternal Medicine-PediatricsMedical Education and SimulationMedical PhysicsMedical StudentNephrologyNeurological SurgeryNeurologyNuclear MedicineNutritionObstetrics and GynecologyOccupational HealthOncologyOphthalmologyOptometryOral MedicineOrthopaedicsOsteopathic MedicineOtolaryngologyPain ManagementPalliative CarePathologyPediatricsPediatric SurgeryPharmacologyPhysical Medicine and RehabilitationPlastic SurgeryPodiatryPreventive MedicinePsychiatryPsychologyPulmonologyRadiation OncologyRadiologyRheumatologySubstance Use and AddictionSurgeryTherapeuticsTraumaUrologyMiscellaneous

A package arrives but you can’t remember ordering anything.

When you open it, you find some cheap, flimsy jewellery.

Is it a case of mistaken identity or has someone accidentally selected the wrong address? You put it to one side and wait to see if anyone claims it or contacts you to ask if you got their gift, but no one does.

While it is far from unusual for parcels to go astray, if one arrives with all your details on it, it is possible you have become an unsuspecting cog in a large-scale “brushing” fraud, a scam that is on the increase, according to online security experts.

Fraudsters need your postage details, which they will often obtain through a data breach. They then set up a false online account in your name on the shopping site they are selling their goods on and post a fake verified and positive review, apparently from you, about the products you have received.

These positive five-star reviews “brush up” their online ranking on the shopping site and also their credibility. In theory, this can then increase their sales. Oliver Devane of the security company McAfee says the goods need to be sent to the customer in order for a purchase and review to be verified. These fake verified reviews are often paid for.

While it may appear to be a victim-free scam, it could highlight that your personal details have been hacked. It also risks bringing potentially harmful toys or cosmetics into your home, says Devane.

“If it is some little toy that you give to your child, you’ve got no idea of the quality … which is a risk in itself. You have no idea where it came from and what it contains,” he says.

What it looks like

The package will come out of the blue and could contain anything from a key chain gadget to random homeware or even plant seeds. The contents will be cheap and likely to be of poor quality. This could happen at any time of the year, although deliveries of the goods peak at busy shopping periods.

In some cases, says Devane, the fraudsters may send QR codes or USB sticks with the product in the hope that people will scan them or put their into their computer. These will invariably lead to some malware being added to a phone or laptop that could result in data being stolen.

What to do

If you get something unexpected in the post, do not use it or consume it as it may be dangerous. For example, a toy may not be produced to proper standards or perfume may have harmful ingredients.

Check your online accounts to make sure there has been no unauthorised order and then report it to the marketplace that it was sent from.

Amazon says third-party sellers are prohibited from sending unsolicited packages to customers and have a way to report them here. If you can identify the fake reviews in your name, then you can inform the shopping site you are dealing with and they can take action.

It is worth changing the password on your online shopping accounts and enabling two-factor authentication, says Devane.

Do not try to return it to the retailer as this may prompt them to engage with you more and initiate more scams. Instead, simply throw it away after reporting it, he says.

Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

Olav Thon Eiendomsselskap (OB:OLT) is drawing attention after its Q4 2025 and full year results, which showed higher sales alongside a weaker bottom line, as well as fresh board changes approved at an extraordinary general meeting.

See our latest analysis for Olav Thon Eiendomsselskap.

Despite the quieter short term price action, with the share price at NOK335.0, Olav Thon Eiendomsselskap’s 1 year total shareholder return of 46.1% and 5 year total shareholder return of 127.79% point to strong compounding and suggest recent earnings and board changes are being weighed against a much longer period of value creation.

If this update has you thinking about where else income focused investors might look in property and beyond, it could be worth broadening your search with 102 top founder-led companies

With revenue at NOK3,996 million, net income at NOK1,884 million for 2025 and the share price at NOK335.0 after a strong multi year return, you have to ask: is there still value here, or is the market already pricing in future growth?

With Olav Thon Eiendomsselskap trading at NOK335.0, its P/E of 14.1x sits below the Norwegian market average of 15.2x and below the peer average of 18.2x. This points to the market assigning a lower earnings multiple than many local and sector comparables.

P/E compares what you pay per share to the company’s earnings per share, so a 14.1x multiple means investors are currently paying NOK14.10 for every NOK1 of annual earnings. For a property rental group that has only recently moved into profit and has a reported Return on Equity of 7.5%, that kind of multiple can reflect a fairly measured view of its earnings power.

Relative to the wider Norwegian market, the 14.1x P/E suggests the share trades at a modest discount to the average company. It is still in line with the broader European real estate sector, which also sits at 14.1x. Compared with its closer real estate peers on 18.2x, the lower P/E signals that the market is not attaching the same earnings premium to Olav Thon Eiendomsselskap as it is to many similar businesses, even after a strong 1 year total shareholder return.

On balance, that mix of in line sector pricing and discount to local peers gives you a clear reference point if you are trying to judge how much expectation is already baked into today’s NOK335.0 share price. See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 14.1x (ABOUT RIGHT)

However, you still have to weigh sector specific risks such as interest rate sensitivity and any meaningful shifts in Norwegian and Swedish retail footfall or office demand.

Find out about the key risks to this Olav Thon Eiendomsselskap narrative.

While the 14.1x P/E makes Olav Thon Eiendomsselskap look reasonably priced against peers, our DCF model tells a different story. With the share price at NOK335 and an estimated future cash flow value of NOK217.91, the stock screens as expensive on this cash flow based view.

That is quite a gap in absolute kroner terms. It really comes down to which lens you trust more: the earnings multiple that lines up with peers, or the cash flow model suggesting less headroom at today’s price?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Olav Thon Eiendomsselskap for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 229 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

If you look at the numbers and reach a different conclusion, or simply prefer your own process, you can shape a full view in minutes: Do it your way

A great starting point for your Olav Thon Eiendomsselskap research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

If Olav Thon Eiendomsselskap has sharpened your thinking, do not stop here. Fresh ideas from different angles can support how you build your portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OLT.OL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

USA Rare Earth, Inc. (NASDAQ:USAR) is among the 10 best meme stocks to buy now. Its shares have returned over 60% year-to-date, with a significant surge in late January after news about the U.S. government backing a $1.6 billion funding.

On January 26, the company announced that it had received a letter of intent for a debt-and-equity package to develop a rare-earth mine in Texas and a magnet-manufacturing facility to boost production of critical materials for the defense and tech sectors, while reducing reliance on China for supply.

Following the development, Roth Capital on January 27 lifted its price target on USA Rare Earth, Inc. (NASDAQ:USAR) to $35 from $25, while maintaining a Buy rating. In a research note to investors, analyst Suji Desilva said the funding would help strengthen the company’s prospects for developing an end-to-end value chain for rare earth materials in the country.

Later on January 30, Cantor Fitzgerald’s Derek Soderberg raised the firm’s price target on the stock to $35 from $28 with an Overweight rating. The analyst noted that magnet production had the potential to generate $1.2 billion in EBITDA by 2030, provided key milestones are achieved.

As of the close of business on February 12, the stock is a Strong Buy with an average share price upside of nearly 94%.

USA Rare Earth, Inc. (NASDAQ:USAR) is engaged in the mining and supply of rare earths and other critical materials.

While we acknowledge the potential of USAR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best American Defense Stocks to Buy According to Wall Street Analysts and 12 Most Profitable NASDAQ Stocks to Buy Right Now.

Disclosure: None.

The introduction of advertisements and sponsored content in chatbots has spawned privacy concerns for AI users as brands scramble to stay relevant in a fast-changing online environment.

ChatGPT developer OpenAI began showing ads in chatbot conversations for free and low-cost users to start balancing its hundreds of billions in spending commitments with new revenue sources.

It swiftly came in for mockery from rival Anthropic, which has staked its reputation on safety and data security.

Anthropic’s advertisement broadcast during last week’s Super Bowl showed a man asking advice from a conversational AI, which then shoehorns advertising copy for a dating site into its otherwise relevant response.

OpenAI boss Sam Altman shot back that the clip was “clearly dishonest”.

Beyond OpenAI, Microsoft has been running contextual ads and sponsored content in its Copilot AI assistant since 2023.

AI search engine Perplexity has been testing ads in the United States since 2024, while Google is also testing ads in the AI “overviews” its namesake search engine has been offering since last year.

– Data privacy –

Google has repeatedly denied wanting to run ads in its Gemini chatbot, with Demis Hassabis — head of the search giant’s DeepMind AI arm — saying that ads “have to be handled very carefully”.

“The most important thing” in AI is “trust in security and privacy, because you want to share potentially your life with that assistant,” he added.

OpenAI has sought to reassure users that ChatGPT’s responses will not be modified by the ads, which are shown alongside conversations rather than being integrated into them.

It has also promised not to sell user data to advertisers.

AI companies are “concerned that selling ads will scare away users,” said Nate Elliott, an analyst with US data firm Emarketer.

But “when it’s free, you’re the product. It’s a risk we’re all more or less aware of already,” said Jerome Malzac of AI consultancy Micropole.

“We accept it because we find value in it.”

If that proves true, advertisers will be delighted to surf the AI wave as it crashes over the world’s internet users.

– Game changer –

“It’s going to be a game changer for the entire industry,” said Justin Seibert, head of Direct Online Marketing.

“We’re already seeing how high the conversion rates (interactions resulting in a purchase) are for people that are coming in from ChatGPT and the other LLMs (large language models),” he added.

AI assistants could account for up to two percent of the online advertising market by 2030, HSBC bank analysts suggested in a report.

Many brands are already prioritising visibility on the new channel, including US supermarket chain Target and software maker Adobe.

Beyond buying a spot on users’ screens, companies are also pushing for their products to appear in chatbots’ organic responses.

The practice is known as GEO (Generative Engine Optimisation) — an evolution of the Search Engine Optimisation strategy during the era of Google’s dominance over the web.

“We identified 90 rules that can make sure the content you create is valued by AI and spread to the right places,” said Joan Burkovic, head of French GEO startup GetMint.

The company already claims 100 clients, including fashion brand Lacoste.

Malzac highlighted techniques like including references to scientific papers, adding a “frequently asked questions” section to your website, and posting information that’s structured and regularly updated, Malzac said.

“If your brand isn’t referenced (by chatbots) it no longer exists” for some users, he warned.

dax-tu/tgb/ach/lb

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

• GE HealthCare Technologies (NasdaqGS:GEHC) has launched ReadyFix, a remote fleet management solution focused on ECG devices, aimed at improving device uptime and configuration across large hospital networks.

• The company also received FDA clearance and CE Marking for Allia Moveo, a compact AI powered interventional imaging system designed to support complex procedures with greater mobility and workflow integration.

For investors watching GE HealthCare at a share price of $80.34, these product moves add context to a stock that shows mixed recent performance, with a 3 year return of 10.3% and a 1 year decline of 12.7%. The combination of a new remote management platform and an AI driven imaging system illustrates how the company is positioning itself within digital and interventional care.

Both ReadyFix and Allia Moveo address hospital pain points around uptime, mobility and procedure efficiency, which are priorities for many providers. As you track NasdaqGS:GEHC, these launches may serve as signposts for how the company is building out its technology stack across device management and advanced imaging.

Stay updated on the most important news stories for GE HealthCare Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on GE HealthCare Technologies.

4 things going right for GE HealthCare Technologies that this headline doesn’t cover.

ReadyFix and Allia Moveo both sit squarely in areas where hospitals are spending to squeeze more value from existing equipment and support more complex procedures. ReadyFix targets a very practical issue for large systems, where biomedical teams manage thousands of connected devices and downtime can disrupt care. Remote diagnostics, standardized configurations and scheduled software updates speak directly to operational efficiency, an area where GE HealthCare competes with Philips and Siemens Healthineers across enterprise imaging and monitoring. Allia Moveo, with its compact, cable free C arm and AI powered guidance tools, is aimed at procedure rooms that need high quality imaging without rebuilding suites from scratch. For investors, these launches link to themes already visible in recent results, where imaging, advanced visualization and pharmaceutical diagnostics have been important contributors alongside a record order backlog. The products also complement management’s focus on more recurring and software rich revenue, as remote fleet tools and AI guidance often come with ongoing service and upgrade contracts. The key question is how quickly large accounts adopt these systems versus alternatives, and whether they help sustain the momentum that allowed GE HealthCare to exceed recent revenue and profit expectations.

• The ReadyFix and Allia Moveo launches line up with the narrative’s focus on new high impact products in imaging and digital solutions that could support future revenue and earnings.

• Success here may test assumptions around tariff and regulatory headwinds, since wider deployment of hardware and software outside the US could still run into the risks highlighted in the narrative.

• The narrative leans heavily on radiopharmaceuticals and major scanners, while this news around remote fleet tools and interventional imaging may not yet be fully reflected in long term storylines about recurring digital revenue.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for GE HealthCare Technologies to help decide what it’s worth to you.

• ⚠️ Analysts have flagged that debt coverage by operating cash flow is a key risk, so heavier investment in new platforms could pressure flexibility if cash generation does not keep pace.

• ⚠️ Competition from peers such as Siemens Healthineers and Philips in interventional imaging and hospital software may limit pricing power or share gains from these launches.

• 🎁 ReadyFix and Allia Moveo support the push into digital and AI powered tools, which can deepen relationships with hospital networks and may support more stable, service based revenue.

• 🎁 The products plug into areas where analysts already see rewards, including good relative value, earnings growth forecasts and a growing role for advanced imaging and visualization.

From here, it is worth tracking how often management calls out ReadyFix and Allia Moveo in order and backlog commentary, and whether hospitals adopt these systems as part of larger enterprise deals. You can also watch how the mix of revenue from digital and service offerings evolves next to hardware sales, since remote fleet tools and AI guidance often go hand in hand with recurring contracts. Given that analysts already highlight both growth opportunities and balance sheet risks, future quarters will show whether new launches support earnings quality without stretching cash flow.

To ensure you’re always in the loop on how the latest news impacts the investment narrative for GE HealthCare Technologies, head to the community page for GE HealthCare Technologies to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include GEHC.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Semiconductor Manufacturing International (SEHK:981) has released its fourth quarter 2025 earnings together with fresh first quarter 2026 guidance, giving investors new revenue, profit and margin markers to evaluate the Hong Kong listed foundry.

See our latest analysis for Semiconductor Manufacturing International.

After the fourth quarter figures and first quarter 2026 guidance, the recent 4.07% 7 day share price return and 0.79% 1 day move contrast with a 9.05% 1 month share price decline. At the same time, the 1 year total shareholder return of 54.45% and roughly 3x 3 year total shareholder return indicate that longer term momentum has been strong despite the softer year to date share price return of 6.32%.

If earnings news around chipmakers has your attention, it could be worth broadening your watchlist with 34 AI infrastructure stocks as another way to find potential beneficiaries of demand for compute capacity.

So with revenue expected to be flat next quarter and the share price pulling back over the past month, is Semiconductor Manufacturing International now trading below what its recent earnings justify, or is the market already counting on future growth?

With Semiconductor Manufacturing International last closing at HK$70.35 against a narrative fair value of HK$74.69, the widely followed view is that the current price sits below what the long term assumptions support.

The analysts have a consensus price target of HK$49.742 for Semiconductor Manufacturing International based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of HK$68.0, and the most bearish reporting a price target of just HK$20.0.

Read the complete narrative.

Want to know what is sitting behind a higher fair value than that consensus target? The narrative leans on steady top line expansion, thicker margins and a rich future earnings multiple. Curious which specific growth and profitability assumptions have to line up for HK$74.69 to make sense?

Result: Fair Value of HK$74.69 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the narrative also flags risks, including reliance on Chinese demand and margin pressure from pricing and heavy capital spending, which could challenge those fair value assumptions.

Find out about the key risks to this Semiconductor Manufacturing International narrative.

The fair value narrative suggests Semiconductor Manufacturing International is 5.8% undervalued at HK$74.69, but the current P/E of 116.1x tells a tougher story. That is much higher than the Asian semiconductor industry at 42.9x, peers at 32.8x, and above a fair ratio of 44.3x.

In practice, that means a lot of optimism is already priced in, so any slip in earnings or sentiment could matter more for the share price. Do you see this as justified confidence, or valuation risk that leaves less room for error?

See what the numbers say about this price — find out in our valuation breakdown.

If parts of this story do not quite line up with your own view, or you prefer to test the assumptions yourself, you can build a custom narrative in just a few minutes and Do it your way.

A great starting point for your Semiconductor Manufacturing International research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.

If Semiconductor Manufacturing International is on your radar, do not stop there. Use the screener to quickly spot other ideas that fit what you are looking for.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 0981.HK.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Specialty

Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI’m not a medical professional.Infectious DiseaseIntegrative/Complementary MedicineInternal MedicineInternal Medicine-PediatricsMedical Education and SimulationMedical PhysicsMedical StudentNephrologyNeurological SurgeryNeurologyNuclear MedicineNutritionObstetrics and GynecologyOccupational HealthOncologyOphthalmologyOptometryOral MedicineOrthopaedicsOsteopathic MedicineOtolaryngologyPain ManagementPalliative CarePathologyPediatricsPediatric SurgeryPharmacologyPhysical Medicine and RehabilitationPlastic SurgeryPodiatryPreventive MedicinePsychiatryPsychologyPulmonologyRadiation OncologyRadiologyRheumatologySubstance Use and AddictionSurgeryTherapeuticsTraumaUrologyMiscellaneous

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.

• Arista Networks (NYSE:ANET) reported record annual financial results for 2025, supported by rising demand tied to AI networking.

• The company raised its 2026 revenue outlook and highlighted a significant contribution from AI related revenues.

• Management pointed to strong international growth as a key factor in the full year performance.

• Arista introduced new networking solutions and expanded its product set aimed at AI and cloud infrastructure workloads.

For you as an investor, the headline is that Arista Networks, a data center and cloud networking specialist, is leaning into the build out of AI and cloud infrastructure. The 2025 record results and higher 2026 revenue outlook are tied directly to this demand, along with broader international uptake of its products. The new offerings focused on generative AI and cloud workloads signal where the company is concentrating its effort.

The key question is whether Arista can sustain interest in its AI focused portfolio as customers scale out networking for larger workloads. You may want to watch how AI related revenues and international sales mix evolve relative to the rest of the business, because those areas now sit at the center of its growth story.

Stay updated on the most important news stories for Arista Networks by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Arista Networks.

We’ve flagged 1 risk for Arista Networks. See which could impact your investment.

For you, the key takeaway is how tightly Arista’s new products are tied to the financial story. In 2025, revenue was US$9.0b compared to US$7.0b a year earlier, with net income of US$3.5b compared to US$2.9b. That performance sits alongside a heavier focus on AI data center and campus networking, including new platforms for high speed switching, AI specific load balancing, and network observability. The 2026 first quarter revenue outlook of about US$2.6b suggests Arista expects that demand for these AI and cloud infrastructure offerings to remain important to its sales mix.

• The strong 2025 results and higher 2026 outlook align with the narrative that AI and cloud workloads are expanding the addressable market for Arista’s Ethernet based networking platforms.

• Heavy reliance on large hyperscale customers, where one or two clients may each contribute over 10% of revenue, still echoes a narrative risk around customer concentration and potential revenue volatility.

• The launch of new campus, SD WAN, and observability products, plus acquisitions like VeloCloud, extends Arista further into enterprise use cases, which is only partly reflected in the original focus on AI data center build outs.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Arista Networks to help decide what it’s worth to you.

• ⚠️ Dependence on a small group of large cloud and AI customers means order timing or spending shifts at a few firms could have an outsized effect on Arista’s revenue path.

• ⚠️ Competition from Cisco, NVIDIA and others in AI networking, plus supply chain factors such as memory costs, could influence pricing, margins, and product availability.

• 🎁 Record 2025 revenue and net income, along with guidance for roughly US$2.6b in first quarter 2026 revenue, highlight how AI networking and international growth are contributing to scale.

• 🎁 Expanded offerings in AI focused switches, load balancing, SD WAN, and observability tools create more ways to participate in AI and cloud-related network spending across data center and enterprise environments.

From here, you may want to watch how much of Arista’s sales are tied to AI networking and whether that share keeps rising as the new product lines mature. It is also worth tracking updates on customer concentration, especially any new clients that approach 10% of revenue, and how margins hold up if memory or component costs stay elevated. Competitive responses from Cisco, NVIDIA and other networking vendors will help you judge whether Arista can keep its current positioning in high performance AI and cloud infrastructure.

To ensure you’re always in the loop on how the latest news impacts the investment narrative for Arista Networks, head to the community page for Arista Networks to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ANET.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

Philip Morris International (PM) shares are back in focus after the company reported fourth quarter and full year 2025 results, shifting from a prior year loss to a profit and spotlighting smoke free products.

See our latest analysis for Philip Morris International.

The earnings rebound and focus on smoke free products have come alongside a strong share price run, with a 30 day share price return of 9.6% and a 1 year total shareholder return of 29.03%. This suggests positive momentum that is also visible in the 3 year and 5 year total shareholder returns of 111.40% and 179.50% respectively, despite a 0.76% share price pullback on the latest trading day to US$187.51.

If this kind of long term compounding has your attention, it could be a good moment to broaden your search and check out our screener of 23 top founder-led companies.

Given the recent profit rebound, the smoke-free growth story, and a share price sitting close to analyst targets yet still screening at around a 12% intrinsic discount, is there still a buying opportunity here, or is the market already pricing in the future?

Philip Morris International’s widely followed fair value estimate of about $180.38 sits a little below the last close at $187.51, which is a useful reference point for how the market is currently treating the stock.

Scale advantages, a broadening product portfolio, and an expanding IP moat in reduced-risk products are driving margin expansion. Smoke-free margins already surpass combustibles by over 4.5 percentage points, and as the mix continues to shift, this is expected to further increase overall net margins and free cash flow.

Read the complete narrative.

Curious what sits behind that confidence in higher margins and cash flows, even with slower growth assumptions baked in and a lower future earnings multiple? The narrative leans heavily on specific revenue trajectories, profitability targets, and a discount rate that together still point to a premium earnings profile. If you want to see exactly how those moving parts add up to a fair value around $180 per share, the full breakdown is worth a closer look.

Result: Fair Value of $180.38 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, there are still pressure points, including potential new taxes on products like ZYN and the ongoing structural decline in cigarette volumes, that could challenge this upbeat fair value story.

Find out about the key risks to this Philip Morris International narrative.

While the popular narrative tags Philip Morris International as about 4% overvalued around $187.51 versus a fair value near $180.38, our DCF model comes to a different conclusion. It indicates the shares are trading at roughly a 12.3% discount to an estimated future cash flow value of $213.73. Which signal do you trust more: price targets or cash flows?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Philip Morris International for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 53 high quality undervalued stocks. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

If you see the numbers differently, or simply prefer to test your own assumptions against the data, you can build a customized view in just a few minutes, then Do it your way.

A great starting point for your Philip Morris International research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

If Philip Morris International is on your radar, do not stop there, the broader market holds plenty of other opportunities worth putting on your watchlist today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include PM.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com